TABLE 5

Factors associated with time to presentation (symptom duration) at secondary care

Crude HR (95% CI)Age-adjusted HR (95% CI)Fully adjusted HR (95% CI)#
Age0.98 (0.98–0.99)0.98 (0.98–0.99)
Sex (male versus female)1.19 (1.03–1.38)1.20 (1.03–1.34)0.85 (0.71–1.02)
Ethnic group
 Indian1.08 (0.85–1.37)
 Pakistani1.10 (0.79–1.53)
 Afghani0.58 (0.46–0.73)
 White0.78 (0.55–1.10)
 Bangladeshi1.03 (0.62–1.72)
 Black0.91 (0.67–1.22)
 Chinese4.27 (3.22–5.67)
HIV1.50 (0.93–2.42)2.08 (1.31–3.30)0.71 (0.46–1.09)
Diabetes1.26 (1.01–1.58)1.09 (0.85–1.40)
Hypertension1.19 (0.96–1.46)1.01 (0.80–1.30)
Renal failure1.11 (0.90–1.37)
Cancer1.33 (0.82–2.16)
Lung disease
 Asthma/COPD1.59 (0.58–4.33)
 Bronchiectasis1.28 (0.54–3.00)
 ILD1.09 (0.33–3.65)
 PE4.04 (1.48–11.00)
PTB versus EPTB1.20 (1.03–1.38)1.17 (1.00–1.37)1.26 (1.05–1.50)

HR: hazard ratio; COPD: chronic obstructive pulmonary disease; ILD: interstitial lung disease; PE: pulmonary embolism; PTB: pulmonary tuberculosis; EPTB: extrapulmonary tuberculosis. #: adjusted for age, sex, HIV and PTB versus EPTB.